Type VP3/4 Portal Vein Tumor Thrombosis
1 clinical trials · Condition
◉ Watch Type VP3/4 Portal Vein Tumor Thrombosis
| Record | Firm | Date |
|---|---|---|
| QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT (NCT07327788) | Nanfang Hospital, Southern Medical University | 2025-12-25 |
Track Type VP3/4 Portal Vein Tumor Thrombosis automatically
Every clearance here is in the API, with alerts when new ones post.